Skip to main content
. 2002 Dec;130(3):501–508. doi: 10.1046/j.1365-2249.2002.02008.x

Fig. 1.

Fig. 1

Fig. 1

Expression of CD83 on PMN of patients with acute bacterial infection. (a) PMN in whole blood were examined by flow cytofluorometry; cells were labelled with CD66b-FITC as a specific marker for PMN and CD83 PE (clone HB15A) or the isotypic-negative control, respectively. The upper panel shows PMN of a patient with infection; here 33·4% of PMN are double-positive for CD66b/CD83 (right upper quadrant). The right panel shows CD64 expression as a ‘positive control’ for PMN activation. The lower panel shows cells of a patient with active Wegener's granulomatosis. (b) Expression of CD83 on PMN of patients with either bacterial infections, or Wegener's granulomatosis, or of healthy donors. Data are shown for patients with acute bacterial infections (n = 26), patients with Wegener's granulomatosis with active disease (BVAS > 2) (n = 7) or inactive disease (n = 12), and healthy donors (n = 22) and is expressed as percentage of CD83-positive PMN. Each dot represents one patient or donor, respectively, The values of the group ‘bacterial infection’ differed from all the others (largest P-value: 0·05).